Oncology

Back to articles

New hope: Anti-angiogenic agent for metastatic colorectal cancer

KEY POINT

In patients with metastatic colorectal cancer previously treated with oxaliplatin, use of ziv-aflibercept (Zaltrap—Sanofi) in combination with FOLFIRI resulted in an improvement in overall survival and progression-free survival and a greater response rate compared with FOLFIRI combined with placebo.